Optimize your drug development pipeline
Our scientific department, located in business development unit delivers robust Pipeline Strategy Analysis to Identifyvaluable portfolio opportunities and effectively manage your portfolio risk
In today dynamic market filled with serious competitors, among key scientific process for successful pipeline arrangements are early molecule selection and prioritization. We provide you with strategic direction to the new product development by deeply evaluating candidate product success factors across the many variables that are important for you and your business.
• Maximizing research area portfolio coverage
• Recommending interesting molecules in accordance with your company expectations and investment capacities.
• Prioritization of identified molecules and development projects according to clinical values and market facts
• Supporting commercial decisions across multiple research areas to serve your current and future needs
• Maximizing efficiency and success of marketing campaigns, KOL connections, ADR management…
• Facilitating the smooth journey of a new product idea through to a marketable product